Bank of New York Mellon Corp - KRONOS BIO INC ownership

KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 83 filers reported holding KRONOS BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KRONOS BIO INC
ValueSharesWeighting
Q3 2023$21,603
-24.4%
16,6180.0%0.00%
Q2 2023$28,583
-85.1%
16,618
-87.4%
0.00%
Q1 2023$192,338
-11.1%
131,738
-1.3%
0.00%
Q4 2022$216,233
-51.6%
133,477
-0.0%
0.00%
Q3 2022$447,000
+0.4%
133,537
+9.2%
0.00%
Q2 2022$445,000
-53.9%
122,243
-8.4%
0.00%
Q1 2022$965,000
-48.6%
133,393
-3.4%
0.00%
Q4 2021$1,878,000
-33.9%
138,134
+1.9%
0.00%
-100.0%
Q3 2021$2,841,000
+4.6%
135,534
+19.6%
0.00%0.0%
Q2 2021$2,715,000
+140.3%
113,355
+193.6%
0.00%
Q1 2021$1,130,000
+1.3%
38,605
+3.3%
0.00%
Q4 2020$1,116,00037,3670.00%
Other shareholders
KRONOS BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,765,314$4,037,3585.52%
Omega Fund Management, LLC 3,818,283$5,574,6933.64%
Nextech Invest Ltd. 1,451,537$2,119,2440.88%
Wildcat Capital Management, LLC 1,297,959$1,895,0200.70%
Privium Fund Management (UK) Ltd 292,182$455,8040.36%
CM Management, LLC 180,000$2630.31%
Artal Group S.A. 1,542,954$2,2530.13%
Alphabet Inc. 1,438,232$2,099,8190.12%
Perceptive Advisors 1,752,745$2,558,1310.08%
GSA CAPITAL PARTNERS LLP 406,362$5930.06%
View complete list of KRONOS BIO INC shareholders